NICE
Neutral signalScored 2026-10-06 Drivers: Congress, fundamentals. Moteurs : Congrès, fondamentaux.
Research, not advice.
À propos
NICE Ltd.
- Nom
- NICE Ltd.
- Secteur
- Technology
- Industrie
- Software - Application
- Bourse
- NASDAQ
- Capitalisation
- $7.1B
- Employés
- 9,626
- PDG
- Scott E. Russell
- Site web
- https://www.nice.com
- Marché
- ACIWFICONCNONDAQVRSK
NICE Ltd., together with its subsidiaries, provides AI-powered cloud platforms for customer engagement, and financial crime and compliance in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Customer Engagement; and Financial Crime and Compliance. The Customer Engagement segment provides CXone Mpower platform for organizations to automate service, augment the workforce with AI-powered solutions, and unify enterprise knowledge, data and AI models resolutions, and customer experiences. The Financial Crime and Compliance segment offers embedded-AI solutions that identify risks and help prevent money laundering and fraud, as well as help ensure financial markets compliance in real-time. It also provides NICE Evidencentral, a digital evidence management and investigation platform for criminal justice system. In addition, the company offers NiCE Actimize provides cloud platforms embedded with AI capabilities for real-time and cross-channel fraud prevention, know-your-customer, anti-money laundering, and capital markets compliance; X-Sight, an open AI-cloud platform for Financial Crime and Compliance, enabling financial services organizations; Xceed which provides AI, data intelligence, machine learning, and insights for AML and fraud prevention for small and mid-sized organizations; cloud platforms provide financial services organizations with the agility required to adapt changing regulatory and threat landscapes; data intelligence solutions enable organizations to turn raw data into actionable intelligence to prevent and detect financial crimes; AI and analytics; intelligent investigations solutions; and self-service solutions. The company was formerly known as NICE-Systems Ltd. and changed its name to NICE Ltd. in June 2016. NICE Ltd. was incorporated in 1986 and is headquartered in Ra'anana, Israel.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Decouvert par les declarations du Congres
- Insiders
- —
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$50,000
Avg sell (VWAP, 90d window) $100.00 vs last close —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- —
- Last synced
-
2026-10-06 10:56:08
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-08-07 | Dayan Udi Yehuda | Sell · S | 500 | $100.00 | $50,000 | Form 4 |
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
| Date | Member | Side | Amount range | Filing |
|---|---|---|---|---|
| 2026-07-20 | Josh Gottheimer | Buy | $1,001 - $15,000 | Filing |
| 2026-07-20 | Josh Gottheimer | Buy | $1,001 - $15,000 | Filing |
| 2026-07-19 | Josh Gottheimer | Buy | $1,001 - $15,000 | Filing |
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-07-20 | Josh S. Gottheimer | Purchase | $1,001 - $15,000 |
| 2025-10-17 | Josh S. Gottheimer | Purchase | $1,001 - $15,000 |
| 2025-07-16 | Lisa C. McClain | Sale (Full) | $1,001 - $15,000 |
| 2023-07-10 | Daniel Goldman | Sale (Full) | $15,001 - $50,000 |
| 2023-01-13 | Daniel Goldman | Sale (Partial) | $1,001 - $15,000 |
| 2020-11-18 | Gilbert Ray Cisneros | Sale (Partial) | $1,001 - $15,000 |
| 2020-07-23 | Gilbert Ray Cisneros | Sale (Partial) | $1,001 - $15,000 |
| 2020-07-21 | Gilbert Ray Cisneros | Sale (Partial) | $1,001 - $15,000 |
Signal
Neutral signalScored 2026-10-06 Drivers: Congress, fundamentals. Moteurs : Congrès, fondamentaux.
NICE exhibits exceptional financial health with strong liquidity (90) and solid fundamental momentum (85), underpinned by a deleveraged balance sheet and robust cash flow generation.
The first sentence of the analysis written for NICE on 2026-10-06 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Unavailable or mixed. 1 purchase disclosure year to date, a thin reading
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Timing Unavailable or mixed. No stored price series
- Financial indicators Supports a bullish reading. Current ratio 1.55 · operating margin 22%
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 66.4% | 66.7% | 67.7% | 68.7% | 67.5% | |
| Ebit Margin | 23.9% | 20.1% | 19.4% | 16.0% | 13.3% | |
| Ebitda Margin | 30.7% | 27.6% | 26.4% | 24.1% | 22.9% | |
| Operating Profit Margin | 21.9% | 20.0% | 18.3% | 15.4% | 13.7% | |
| Pretax Profit Margin | 23.9% | 22.1% | 19.3% | 15.8% | 12.5% | |
| Continuous Operations Profit Margin | 20.8% | 16.2% | 14.2% | 12.2% | 10.4% | |
| Net Profit Margin | 20.8% | 16.2% | 14.2% | 12.2% | 10.4% | |
| Bottom Line Profit Margin | 20.8% | 16.2% | 14.2% | 12.2% | 10.4% | |
| Current Ratio | 1.554 | 1.699 | 2.064 | 2.118 | 1.810 | |
| Quick Ratio | 1.554 | 1.699 | 2.064 | 2.118 | 1.810 | |
| Solvency Ratio | 0.660 | 0.383 | 0.287 | 0.246 | 0.205 | |
| Cash Ratio | 0.427 | 0.327 | 0.457 | 0.464 | 0.298 | |
| Price To Earnings Ratio | 11.511 | 24.367 | 37.502 | 46.115 | 96.381 | |
| Price To Earnings Growth Ratio | 0.282 | 0.786 | 1.360 | 1.424 | 302.636 | |
| Forward Price To Earnings Growth Ratio | 0.282 | 0.786 | 1.360 | 1.424 | 302.636 | |
| Price To Earnings Diluted Ratio | 11.690 | 25.124 | 39.043 | 48.075 | 101.879 | |
| Price To Earnings Diluted Growth Ratio | 0.272 | 0.778 | 1.407 | 1.405 | 0.000 | |
| Price To Book Ratio | 1.818 | 3.004 | 3.797 | 4.032 | 6.791 | |
| Price To Sales Ratio | 2.392 | 3.942 | 5.336 | 5.624 | 9.986 | |
| Price To Free Cash Flow Ratio | 10.021 | 14.712 | 26.583 | 30.835 | 48.616 | |
| Price To Operating Cash Flow Ratio | 9.756 | 12.949 | 22.597 | 25.571 | 41.541 | |
| Debt To Assets Ratio | 0.032 | 0.106 | 0.153 | 0.160 | 0.197 | |
| Debt To Equity Ratio | 0.042 | 0.157 | 0.234 | 0.256 | 0.328 | |
| Debt To Capital Ratio | 0.041 | 0.136 | 0.190 | 0.204 | 0.247 | |
| Long Term Debt To Capital Ratio | 0.019 | 0.000 | 0.120 | 0.130 | 0.132 | |
| Financial Leverage Ratio | 1.317 | 1.475 | 1.532 | 1.596 | 1.667 | |
| Working Capital Turnover Ratio | 3.871 | 2.461 | 1.926 | 1.893 | 1.995 | |
| Operating Cash Flow Ratio | 0.814 | 0.565 | 0.501 | 0.420 | 0.364 | |
| Operating Cash Flow Sales Ratio | 0.245 | 0.304 | 0.236 | 0.220 | 0.240 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.974 | 0.880 | 0.850 | 0.829 | 0.854 | |
| Debt Service Coverage Ratio | 59.028 | 1.275 | 2.343 | 2.038 | 0.930 | |
| Interest Coverage Ratio | 0.000 | 103.597 | 53.200 | 34.590 | 7.924 | |
| Short Term Operating Cash Flow Coverage Ratio | 52.557 | 1.815 | 2.683 | 2.292 | 1.166 | |
| Operating Cash Flow Coverage Ratio | 4.408 | 1.477 | 0.717 | 0.617 | 0.499 | |
| Capital Expenditure Coverage Ratio | 37.873 | 8.346 | 6.669 | 5.858 | 6.871 | |
| Dividend Paid And Capex Coverage Ratio | 37.873 | 8.346 | 6.669 | 5.858 | 6.871 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 7.564 | 14.406 | 20.609 | 23.811 | 44.795 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 66.4% | ▼-0.3% | ▼-1.0% |
| Ebit Margin | 23.9% | ▲3.8% | ▲5.4% |
| Ebitda Margin | 30.7% | ▲3.1% | ▲4.3% |
| Operating Profit Margin | 21.9% | ▲2.0% | ▲4.1% |
| Pretax Profit Margin | 23.9% | ▲1.8% | ▲5.2% |
| Continuous Operations Profit Margin | 20.8% | ▲4.6% | ▲6.0% |
| Net Profit Margin | 20.8% | ▲4.6% | ▲6.0% |
| Bottom Line Profit Margin | 20.8% | ▲4.6% | ▲6.0% |
| Current Ratio | 1.554 | ▼-0.145 | ▼-0.295 |
| Quick Ratio | 1.554 | ▼-0.145 | ▼-0.295 |
| Solvency Ratio | 0.660 | ▲0.277 | ▲0.304 |
| Cash Ratio | 0.427 | ▲0.101 | ▲0.033 |
| Price To Earnings Ratio | 11.511 | ▼-12.856 | ▼-31.664 |
| Price To Earnings Growth Ratio | 0.281 | ▼-0.504 | ▼-61.016 |
| Forward Price To Earnings Growth Ratio | 0.281 | ▼-0.504 | ▼-61.016 |
| Price To Earnings Diluted Ratio | 11.690 | ▼-13.434 | ▼-33.472 |
| Price To Earnings Diluted Growth Ratio | 0.272 | ▼-0.506 | ▼-0.501 |
| Price To Book Ratio | 1.818 | ▼-1.186 | ▼-2.071 |
| Price To Sales Ratio | 2.392 | ▼-1.550 | ▼-3.064 |
| Price To Free Cash Flow Ratio | 10.021 | ▼-4.691 | ▼-16.133 |
| Price To Operating Cash Flow Ratio | 9.756 | ▼-3.193 | ▼-12.727 |
| Debt To Assets Ratio | 0.032 | ▼-0.074 | ▼-0.098 |
| Debt To Equity Ratio | 0.042 | ▼-0.115 | ▼-0.161 |
| Debt To Capital Ratio | 0.041 | ▼-0.095 | ▼-0.123 |
| Long Term Debt To Capital Ratio | 0.019 | ▲0.019 | ▼-0.061 |
| Financial Leverage Ratio | 1.317 | ▼-0.158 | ▼-0.200 |
| Working Capital Turnover Ratio | 3.871 | ▲1.410 | ▲1.442 |
| Operating Cash Flow Ratio | 0.814 | ▲0.249 | ▲0.281 |
| Operating Cash Flow Sales Ratio | 0.245 | ▼-0.059 | ▼-0.004 |
| Free Cash Flow Operating Cash Flow Ratio | 0.974 | ▲0.093 | ▲0.096 |
| Debt Service Coverage Ratio | 59.028 | ▲57.752 | ▲45.905 |
| Interest Coverage Ratio | 0.000 | ▼-103.597 | ▼-39.862 |
| Short Term Operating Cash Flow Coverage Ratio | 52.557 | ▲50.743 | ▲40.455 |
| Operating Cash Flow Coverage Ratio | 4.408 | ▲2.930 | ▲2.864 |
| Capital Expenditure Coverage Ratio | 37.873 | ▲29.527 | ▲24.749 |
| Dividend Paid And Capex Coverage Ratio | 37.873 | ▲29.527 | ▲24.749 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 7.564 | ▼-6.842 | ▼-14.673 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $7.05B | $10.78B | $12.69B | $12.27B | $19.18B | |
| Enterprise value | $6.83B | $10.86B | $12.96B | $12.51B | $19.73B | |
| EV / Sales | 2.32x | 3.97x | 5.45x | 5.74x | 10.27x | |
| EV / Op. cash flow | 9.46x | 13.05x | 23.08x | 26.09x | 42.73x | |
| EV / Free cash flow | 9.71x | 14.82x | 27.15x | 31.46x | 50.00x | |
| EV / EBITDA | 7.56x | 14.41x | 20.61x | 23.81x | 44.80x | |
| Net debt / EBITDA | -0.24x | 0.11x | 0.43x | 0.47x | 1.24x | |
| Current ratio | 1.55x | 1.70x | 2.06x | 2.12x | 1.81x | |
| Income quality | 1.17x | 1.88x | 1.66x | 1.80x | 2.32x | |
| Graham number | $117 | $94 | $79 | $67 | $56 | |
| Graham net-net | -$4 | $7 | $1 | $3 | -$2 | |
| Tax burden | 86.9% | 73.2% | 73.9% | 77.0% | 82.8% | |
| Interest burden | 100.0% | 110.1% | 99.2% | 98.9% | 93.8% | |
| Working capital | $491.5M | $1.03B | $1.19B | $1.28B | $1.03B | |
| Invested capital | $3.79B | $3.39B | $3.60B | $3.36B | $3.16B | |
| Return on assets | 12.0% | 8.4% | 6.6% | 5.5% | 4.2% | |
| Operating ROA | 12.4% | 10.5% | 8.7% | 7.0% | 5.9% | |
| Return on tangible assets | 29.5% | 13.8% | 11.3% | 8.8% | 7.1% | |
| Return on equity | 15.8% | 12.3% | 10.1% | 8.7% | 7.1% | |
| Return on invested capital | 13.3% | 9.3% | 7.6% | 6.6% | 5.7% | |
| Return on capital employed | 15.3% | 14.3% | 10.9% | 9.0% | 7.7% | |
| Earnings yield | 8.7% | 4.1% | 2.7% | 2.2% | 1.0% | |
| Free cash flow yield | 10.0% | 6.8% | 3.8% | 3.2% | 2.1% | |
| Capex / Op. cash flow | 2.6% | 12.0% | 15.0% | 17.1% | 14.6% | |
| Capex / Depreciation | 9.6% | 48.7% | 50.3% | 46.4% | 36.5% | |
| Capex / Sales | 0.6% | 3.6% | 3.5% | 3.8% | 3.5% | |
| SG&A / Sales | 32.3% | 33.5% | 35.8% | 39.3% | 39.6% | |
| R&D / Sales | 12.2% | 13.2% | 13.6% | 14.0% | 14.1% | |
| Stock comp / Sales | 5.0% | 6.7% | 7.4% | 8.4% | 8.0% | |
| Intangibles / Total assets | 59.3% | 39.3% | 41.6% | 37.6% | 40.4% | |
| Days sales outstanding | 91d | 86d | 90d | 87d | 76d | |
| Days payables outstanding | 37d | 44d | 31d | 30d | 21d | |
| Operating cycle | 91d | 86d | 90d | 87d | 76d | |
| Cash conversion cycle | 54d | 42d | 58d | 57d | 55d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Recent news
- 2026-10-05 Should You Invest in Nice (NICE) Based on Bullish Wall Street Views? Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock''s price, do they really matter?
- 2026-10-05 NiCE Names Carahsoft Distributor of the Year for 2025 Company Recognized for Connecting Public Sector Organizations With AI-Powered Customer Service Solutions Company Recognized for Connecting Public Sector Organizations With AI-Powered Customer Service Solutions
- 2026-10-02 Nice (NICE) Stock Declines While Market Improves: Some Information for Investors In the closing of the recent trading day, Nice (NICE) stood at $113.81, denoting a -2.3% move from the preceding trading day.
- 2026-10-01 NiCE Named a Leader in the IDC MarketScape for Worldwide Agentic Contact Center-as-a-Service Platforms HOBOKEN, N.J.--(BUSINESS WIRE)--NiCE (Nasdaq: NICE) today announced it has been positioned in the Leaders category in the IDC MarketScape: Worldwide Agentic Contact Center–as-a-Service Platforms 2026 Vendor Assessment (doc #US54117326, August 2026). We believe NiCE''s position underscores the strength of its unified CX AI platform, bringing CXone and NiCE Cognigy together to orchestrate every interaction across AI agents, human agents and enterprise workflows. This unified approach enables organ.
- 2026-10-01 NICE issues final draft guidance recommending ▼ Tryngolza® (olezarsen) as an option to treat genetically confirmed familial chylomicronaemia syndrome (FCS) in adults in England and Wales CAMBRIDGE, England--(BUSINESS WIRE)--FOR UK HEALTHCARE/TRADE MEDIA ONLY Sobi® UK today announced that the National Institute for Health and Care Excellence (NICE) has issued final draft guidance which recommends Tryngolza® (olezarsen) as an option to treat genetically confirmed familial chylomicronaemia syndrome (FCS) in adults in England and Wales, only if response to diet and conventional triglyceride-lowering treatments (such as statins and fibrates) has been inadequate. FCS is an ultra-rare.
- 2026-09-30 NICE: Growth Numbers Look Ugly, But The Setup Is Improving NICE Ltd. remains a Buy, with AI-driven growth and a low valuation underpinning the investment thesis. AI and Self-Service ARR surged 52% year-over-year, now 15% of cloud revenue, signaling robust demand and platform relevance. Margin compression persists as NICE invests in AI and expansion, but strong cash flow and buybacks provide downside protection.
- 2026-09-30 This Nice Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- 2026-09-30 Here Are Wednesday’s Top Wall Street Analyst Research Calls: Ally Financial, BankUnited, Ciena Corporation, CoreWeave, Dow, FormFactor, Lumentum Holdings, Moderna, Target, and More Rising Treasury yields are rattling markets heading into the final trading day of Q3, and Wall Street analysts are making bold moves on a wide range of stocks from big-box retail to AI infrastructure. Find out who got cut and who got a fresh vote of confidence.
- 2026-09-28 Is NICE Ltd (NICE) a Bargain After 3.3% Drop? GF Value Says Undervalued On September 28, 2026, NICE Ltd (NICE) shares fell 3.3% to a current price of $109.09, continuing a downward trend with a 52-week range between $83.10 and $149.
- 2026-09-28 Nice (NICE) is Attracting Investor Attention: Here is What You Should Know Nice (NICE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock''s prospects.